Li Bo, Kim Ji-Youn, Martis Renita M, Donaldson Paul J, Lim Julie C
Department of Physiology, University of Auckland, New Zealand.
New Zealand-National Eye Centre, University of Auckland, New Zealand.
Transl Vis Sci Technol. 2020 Jul 28;9(8):37. doi: 10.1167/tvst.9.8.37. eCollection 2020 Jul.
To investigate whether human donor lenses are capable of exporting reduced glutathione.
Human lenses of varying ages were cultured in artificial aqueous humor for 1 hour under hypoxic conditions to mimic the physiologic environment and reduced glutathione (GSH) and oxidized glutathione (GSSG) levels measured in the media and in the lens.
Human donor lenses released both GSH and GSSG into the media. Donor lenses cultured in the presence of acivicin, a γ-glutamyltranspeptidase inhibitor, exhibited a significant increase in GSSG levels ( < 0.05), indicating that GSSG undergoes degradation into its constituent amino acids. Screening of GSH/GSSG efflux transporters revealed Mrp1, Mrp4, and Mrp5 to be present at the transcript level, but only Mrp5 was expressed at the protein level. Blocking Mrp5 function with the Mrp inhibitor MK571 led to a significant decrease in GSSG efflux ( < 0.05), indicating that Mrp5 is likely to be involved in mediating GSSG efflux. Measurements of efflux from the anterior and posterior surface of the lens revealed that GSH and GSSG efflux occurs at both surfaces but predominantly at the anterior surface.
Human lenses export GSH and GSSG into the surrounding ocular humors, which can be recycled by the lens to maintain intracellular GSH homeostasis or used by neighboring tissues to maintain GSH levels.
Early removal of a clear lens, as occurs to treat myopia and presbyopia, would eliminate this GSH reservoir and reduce the supply of GSH to other tissues, which, over time, may have clinical implications for the progression of other ocular diseases associated with oxidative stress.
研究人供体晶状体是否能够输出还原型谷胱甘肽。
将不同年龄的人晶状体在人工房水中于缺氧条件下培养1小时,以模拟生理环境,并测定培养基和晶状体中还原型谷胱甘肽(GSH)和氧化型谷胱甘肽(GSSG)的水平。
人供体晶状体将GSH和GSSG都释放到培养基中。在γ-谷氨酰转肽酶抑制剂阿西维辛存在的情况下培养的供体晶状体,其GSSG水平显著升高(<0.05),表明GSSG降解为其组成氨基酸。对GSH/GSSG外流转运体的筛选显示,Mrp1、Mrp4和Mrp5在转录水平存在,但只有Mrp5在蛋白质水平表达。用Mrp抑制剂MK571阻断Mrp5功能导致GSSG外流量显著减少(<0.05),表明Mrp5可能参与介导GSSG外流。对晶状体前表面和后表面的外流测量显示,GSH和GSSG外流在两个表面都发生,但主要发生在前表面。
人晶状体将GSH和GSSG输出到周围眼液中,晶状体可将其循环利用以维持细胞内GSH稳态,或被邻近组织利用以维持GSH水平。
如在治疗近视和老花眼时那样早期摘除透明晶状体,将消除这个GSH储备库,并减少向其他组织的GSH供应,随着时间的推移,这可能对与氧化应激相关的其他眼部疾病的进展产生临床影响。